Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nucliray ApS
APS
Active
Advertising protection
CVR 44774143
Borgmestervangen 31, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 2 years old
— employees
www.nucliray.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Nucliray ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Income statement
DKK thousands
Item
2024
Gross profit
-34
Staff expenses
-0
EBITDA
-34
Depreciation & amort.
-0
EBIT
-34
Net financials
0
Profit before tax
-34
Tax
-0
Net profit
-34
Balance sheet
DKK thousands
Item
2024
Total assets
16
Equity
6
Long-term debt
0
Short-term debt
10
Total debt
10
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-3426500.0%
This company
2024
2024
Equity ratio
36.4%
This company
38.2%
Market median
+5% vs market
2024
2024
Return on equity
-597.5%
This company
18.4%
Market median
-3347% vs market
2024
2024
Net profit margin (of gross profit)
-3426500.0%
This company
2024
2024
Asset turnover (of gross profit)
-2.18×
This company
2024
2024
Debt / equity
1.74×
This company
0.62×
Market median
-181% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-04-16 – 2024-12-31
View
PDF
More on Nucliray ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
